Abstract：Progressive familial intrahepatic cholestasis type I (PFIC1) is an autosomal recessive disorder caused by biallelic mutations of ATP8B1 gene, with progressive cholestasis as the main clinical manifestation. This paper reports the clinical and genetic features of a PFIC1 patient definitely diagnosed by ATP8B1 genetic analysis. The patient, a boy aged 14 months, was referred to the hospital with the complaint of jaundiced skin and sclera over 10 months. The patient had been managed in different hospitals, but the therapeutic effects were unsatisfactory due to undetermined etiology. On physical examination, hepatosplenomegaly was discovered in addition to jaundice of the skin and sclera. The liver was palpable 4 cm below the right subcostal margin and 2 cm below the xiphoid while the spleen 2 cm below the left subcostal margin. The liver function test revealed elevated levels of serum total bile acids, bilirubin, and transaminases; however, the γ-glutamyl transferase level was normal. The diagnosis was genetic cholestasis of undetermined origin. At the age of 1 year and 8 months, a Roux-en-Y cholecystocolonic bypass operation was performed, and thereafter the jaundice disappeared. At 5 years and 1 month, via whole genome sequencing analysis and Sanger sequencing confirmation, the boy was found to be a homozygote of mutation c.2081T > A (p.I694N) of ATP8B1 gene, and thus PFIC1 was definitely diagnosed. The boy was followed up until he was 6 years, and jaundice did not recur, but the long-term outcome remains to be observed.
CHENG Ying,GUO Li,SONG Yuan-Zong. Clinical feature and ATP8B1 mutation analysis of a patient with progressive familial intrahepatic cholestasis type I[J]. CJCP, 2016, 18(8): 751-756.
Yang Y,Muzny DM,Reid JG,et al.Clinical whole-exome sequencing for the diagnosis of mendelian disorders[J].N Engl J Med,2013,369(16):1502-1511.
[1]
Yu Y,Xu C,Pan X,et al.Identification and functional analysis of novel mutations of the CLCNKB gene in Chinese patients with classic Bartter syndrome[J].Clin Genet,2010,77(2):155-162.
Shigemizu D,Fujimoto A,Akiyama S,et al.A practical method to detect SNVs and indels from whole genome and exome sequencing data[J].Sci Rep,2013,3:2161.
[3]
Akuma AO,Mittal SK,Sambo AA.Neonatal Bartter syndrome associated with ileal atresia and cystic fibrosis[J].Indian J Nephrol,2013,23(1):47-50.
[4]
Wang XM,Shen Z,Xu M,et al.A Chinese girl with Bartter Syndrome Type Ⅲ due to a novel mutation and/or single nucleotide polymorphisms (SNPs) in CLCNKB gene[J].Iran J Pediatr,2013,23(1):89-94.
[5]
Lee BH,Cho HY,Lee H,et al.Genetic basis of Bartter syndrome in Korea[J].Nephrol Dial Transplant,2012,27(4):1516-1521.
[6]
Robitaille P,Merouani A,He N,et al.Bartter syndrome in two sisters with a novel mutation of the CLCNKB gene,one with deafness[J].Eur J Pediatr,2011,170(9):1209-1211.
[19]
van der Velden LM,Stapelbroek JK,Krieger E,et al.Folding defects in P-type ATP8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate[J].Hepatology,2010,51(1):286-296.
[20]
van Mil SW,Klomp LW,Bull LN,et al.FIC1 disease:a spectrum of intrahepatic cholestatic disorders[J].Semin Liver Dis,2001,21(4):535-544.
[21]
Doğancı T,Akyol G,Bulac S.Progressive familial intrahepatic cholestasis with normal GGT level appearing with lichenification and enlargement of hands and feet[J].Turk J Pediatr,2005,47(4):385-389.
[22]
Jacquemin E,Hermans D,Myara A,et al.Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis[J].Hepatology,1997,25(3):519-523.
[23]
Diao M,Li L,Zhang JS,et al.Laparoscopic cholecystoco-lostomy:a novel surgical approach for the treatment of progressive familial intrahepatic cholestasis[J].Ann Surg,2012,258(6):1028-1033.
